Raynews

Rayner marks 5 millionth RayOne lens sold

Posted on 5/04/2024

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, proudly announces delivery of its 5 millionth RayOne lens (and 11 millionth lens made from RayAcryl Rayner’s

Read more


Rayner announces packaging updates to reduce environmental impact

Posted on 25/03/2024

Rayner, a global manufacturer of products for cataract surgery headquartered in Worthing, UK, is proud to introduce their latest packaging, updated to reduce their carbon footprint, as a contribution to

Read more


RayOne EMV (Rayner) Receives Health Canada Approval

Posted on 23/01/2024

Mississauga, ON, 23 January 2024 Rayner, a global leader in products for cataract surgery, proudly announces the approval of RayOne EMV (RAO200E) by Health Canada1. Developed in collaboration with Professor

Read more


Rayner announces acquisition of Sophi

Posted on 16/01/2024

17/01/2024 | Rayner, a global leader in products for cataract surgery, headquartered in Worthing, UK, announces today that it has entered into a definitive agreement to acquire Swiss-based This AG,

Read more


Rayner achieves top 17% score in 2023 EcoVadis ratings

Posted on 21/12/2023

Rayner, a global manufacturer of products for cataract surgery, is delighted to have scored within the top 17% of companies in the 2023 EcoVadis ratings. EcoVadis is the world’s largest

Read more


Rayner welcomes beehives to global headquarters to contribute to environmental goals

Posted on 14/12/2023

Rayner, a global manufacturer of products for cataract surgery headquartered in Worthing, UK, has introduced a number of beehives to their site to contribute towards their environmental and social responsibility

Read more


Rayner Unveils Exciting Enhancements to Digital Platforms at ESCRS 2023, Booth B303

Posted on 4/09/2023

Worthing, United Kingdom – Rayner, a pioneering leader in ophthalmic innovation, is thrilled to announce a series of ground-breaking updates to its digital platforms, RayPRO and Peer2Peer, set to redefine

Read more


Rayner Achieves Milestone Implantations in Landmark Clinical Trials in China and the USA

Posted on 11/08/2023

Worthing, United Kingdom – August 11, 2023: Rayner, a global ophthalmic leader in Devices, Drugs and Digital, is pleased to announce the successful completion of the first implantations in two

Read more


Rayner Achieves Major Milestone With Implantation of 4 Millionth RayOne IOL

Posted on 25/07/2023

Rayner, a renowned global leader in innovative ophthalmic solutions and the pioneering manufacturer of the world’s first intraocular lens (IOL) in 1949, proudly announces a significant achievement in their ongoing

Read more


Rayner Appoints Geoff Allan as Chief Financial Officer

Posted on 28/04/2023

Worthing, UK, 24 April 2023 – Rayner, a global leader in Drugs, Devices and Digital ophthalmic solutions, announced today that Geoff Allan has been appointed as Chief Financial Officer (CFO)

Read more